Ralf Baron

Ralf Baron's AcademicInfluence.com Rankings

Ralf Baron

Philosophy

#4629

World Rank

#7220

Historical Rank

Logic

#2049

World Rank

#2946

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Ralf Baron Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ralf Baron's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis (2015) (2434)
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values (2006) (1965)
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision (2010) (1688)
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain (2006) (1645)
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment (2010) (1285)
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. (2010) (1185)
A new definition of neuropathic pain (2011) (1046)
NeuPSIG guidelines on neuropathic pain assessment (2011) (942)
Neuropathic pain (2017) (851)
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes (2010) (824)
Mechanisms of Disease: neuropathic pain—a clinical perspective (2006) (747)
Neuropathic pain: an updated grading system for research and clinical practice (2016) (708)
Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms (2012) (679)
Clinical features and pathophysiology of complex regional pain syndrome (2011) (536)
Using screening tools to identify neuropathic pain (2007) (528)
Postherpetic Neuralgia: Irritable Nociceptors and Deafferentation (1998) (508)
EFNS guidelines on neuropathic pain assessment: revised 2009 (2010) (489)
Translation of symptoms and signs into mechanisms in neuropathic pain (2003) (468)
Complex regional pain syndrome: mystery explained? (2003) (436)
Reference data for quantitative sensory testing (QST): Refined stratification for age and a novel method for statistical comparison of group data (2010) (425)
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus (2013) (420)
The IASP classification of chronic pain for ICD-11: chronic neuropathic pain (2019) (389)
Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles (2016) (388)
Do we need a third mechanistic descriptor for chronic pain states? (2016) (377)
Neuropathic pain: principles of diagnosis and treatment. (2015) (372)
Complex Regional Pain Syndromes: guidelines for therapy. (1998) (366)
The motor system shows adaptive changes in complex regional pain syndrome. (2007) (348)
Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study (2003) (340)
Peripheral Neuropathic Pain: From Mechanisms to Symptoms (2000) (336)
Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. (2001) (328)
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations (2010) (323)
Topical menthol--a human model for cold pain by activation and sensitization of C nociceptors. (2004) (301)
Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version (2015) (286)
A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms (2009) (278)
Test–retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): A multi-centre study (2011) (275)
Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study (2002) (266)
Neuropathic pain: a clinical perspective. (2009) (245)
The pathophysiology of parkinsonian tremor: a review (2000) (231)
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations (2012) (229)
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations (2016) (229)
Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach (2012) (226)
The evaluation of neuropathic components in low back pain (2009) (225)
Assessment of neuropathic pain in primary care. (2009) (224)
Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain (2014) (223)
Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. (1999) (218)
Complex regional pain syndrome is a disease of the central nervous system (2002) (217)
Causalgia and reflex sympathetic dystrophy: Does the sympathetic nervous system contribute to the generation of pain? (1999) (214)
Peripheral input and its importance for central sensitization (2013) (207)
Complex regional pain syndrome – diagnostic, mechanisms, CNS involvement and therapy (2003) (204)
Assessment of Chronic Pain: Domains, Methods, and Mechanisms. (2016) (193)
Brain processing of capsaicin-induced secondary hyperalgesia (1999) (189)
Osteoarthritis pain: nociceptive or neuropathic? (2014) (189)
Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care – short version (2010) (185)
Sensory signs in complex regional pain syndrome and peripheral nerve injury (2012) (181)
Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs (2014) (172)
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study (2009) (170)
Pseudoradicular and radicular low-back pain – A disease continuum rather than different entities? Answers from quantitative sensory testing (2008) (167)
Neuropathic low back pain in clinical practice (2016) (159)
Postherpetic neuralgia: Topical lidocaine is effective in nociceptor–deprived skin (2005) (157)
Complex regional pain syndromes (2001) (156)
Skin temperature side differences – a diagnostic tool for CRPS? (2002) (152)
Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT) (2006) (152)
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Reference data for the trunk and application in patients with chronic postherpetic neuralgia (2014) (152)
Postherpetic neuralgia. Are C-nociceptors involved in signalling and maintenance of tactile allodynia? (1993) (146)
The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy (2010) (144)
Fibromyalgia and neuropathic pain - differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia (2011) (139)
Reflex sympathetic dystrophy: Skin blood flow, sympathetic vasoconstrictor reflexes and pain before and after surgical sympathectomy (1996) (138)
A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. (2010) (138)
Transient Receptor Potential Channel Polymorphisms Are Associated with the Somatosensory Function in Neuropathic Pain Patients (2011) (133)
Platelet–leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? (2004) (121)
The painDETECT project – far more than a screening tool on neuropathic pain (2016) (120)
Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations (2017) (119)
Diagnosis and assessment of neuropathic pain through questionnaires (2018) (118)
Traumatic neuralgias: complex regional pain syndromes (reflex sympathetic dystrophy and causalgia): clinical characteristics, pathophysiological mechanisms and therapy. (1998) (111)
Postherpetic neuralgia: epidemiology, pathophysiology and management (2007) (111)
Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. (2021) (108)
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations. (2017) (108)
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel (2011) (107)
Assessing symptom profiles in neuropathic pain clinical trials: Can it improve outcome? (2011) (107)
Histamine-induced itch converts into pain in neuropathic hyperalgesia (2001) (102)
European expert consensus statement on therapeutic goals in Fabry disease. (2018) (97)
Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy (2009) (96)
[How neuropathic is sciatica? The mixed pain concept]. (2004) (95)
Modelling the prevalence and cost of back pain with neuropathic components in the general population (2009) (95)
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations (2014) (95)
Mechanism-based treatment in complex regional pain syndromes (2014) (93)
Neuropathic Pain: Mechanism-Based Therapeutics. (2020) (93)
Effect of sympathetic activity on capsaicin-evoked pain, hyperalgesia, and vasodilatation (1999) (92)
Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: Comparison of different diagnostic modalities (2009) (90)
The Pharmacological Therapy of Chronic Neuropathic Pain. (2016) (88)
Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. (2007) (87)
Endothelial dysfunction in cold type complex regional pain syndrome (2006) (82)
Complex Regional Pain Syndromes: The Influence of Cutaneous and Deep Somatic Sympathetic Innervation on Pain (2006) (81)
Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study (2012) (80)
Pharmacotherapy for neuropathic pain in adults: systematic review, meta-analysis and updated NeuPSIG recommendations (2015) (79)
Harlequin syndrome - one face of many etiologies (2005) (78)
Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease (2010) (77)
Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy (2018) (76)
Treatment considerations for elderly and frail patients with neuropathic pain. (2010) (73)
The effect of menthol on cold allodynia in patients with neuropathic pain. (2008) (72)
Topical 5% Lidocaine (Lignocaine) Medicated Plaster Treatment for Post-Herpetic Neuralgia (2009) (72)
Axial Low Back Pain: One Painful Area – Many Perceptions and Mechanisms (2013) (72)
Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson’s disease (2006) (71)
Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain (2016) (71)
Sensory Symptom Profiles and Co-Morbidities in Painful Radiculopathy (2011) (71)
What is localized neuropathic pain? A first proposal to characterize and define a widely used term. (2012) (70)
Herpes Zoster and Postherpetic Neuralgia (2008) (68)
Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type (2016) (67)
Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study (2010) (67)
Complex regional pain syndromes—how do we escape the diagnostic trap? (2004) (64)
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial (2016) (64)
Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐Label, Phase 3b/4 Study (2016) (64)
Quantitative sensory testing using DFNS protocol in Europe: an evaluation of heterogeneity across multiple centers in patients with peripheral neuropathic pain and healthy subjects (2016) (64)
Topical 5 % Lidocaine ( Lignocaine ) Medicated Plaster Treatment for PostHerpetic Neuralgia Results of a Double-Blind , Placebo-Controlled , Multinational Efficacy and Safety Trial (2012) (64)
Disease mechanisms in neuropathic itch (2008) (64)
Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study (2015) (63)
Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models (2018) (63)
Quantitative sensory testing (QST). English version (2016) (62)
Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendations (2015) (61)
Capsaicin and nociception: from basic mechanisms to novel drugs (2000) (61)
Persistent Spinal Pain Syndrome: A Proposal for Failed Back Surgery Syndrome and ICD-11 (2021) (61)
Neuropathic Pain (2016) (59)
Who is healthy? Aspects to consider when including healthy volunteers in QST-based studies—a consensus statement by the EUROPAIN and NEUROPAIN consortia (2015) (59)
Is CRPS I a neuropathic pain syndrome? (2006) (59)
Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting (2015) (57)
Toward a definition of pharmacoresistant neuropathic pain (2009) (56)
National Institutes of Health Workshop: Reflex Sympathetic Dystrophy/Complex Regional Pain Syndromes— State-of-the-Science (2002) (56)
Afferent large fiber polyneuropathy predicts the development of postherpetic neuralgia (1997) (55)
Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy (2009) (53)
Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study* (2009) (52)
Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. (2005) (52)
A pharmacological treatment algorithm for localized neuropathic pain (2016) (51)
Prevention and treatment of postherpetic neuralgia (2006) (50)
Dynamic mechanical allodynia in humans is not mediated by a central presynaptic interaction of Aβ-mechanoreceptive and nociceptive C-afferents (1999) (49)
Experimental approach to CRPS (2004) (49)
Neuropathic pain needs systematic classification (2013) (49)
Nail changes secondary to docetaxel (2001) (48)
Topical high-concentration (40%) menthol-somatosensory profile of a human surrogate pain model. (2011) (48)
Paper versus electronic rating scales for pain assessment: a prospective, randomised, cross-over validation study with 200 chronic pain patients (2008) (47)
The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts. (2019) (46)
Corrigendum to “Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values” [Pain 123 (2006) 231–243] (2006) (44)
Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. (2009) (44)
Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data (2017) (44)
Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies (2008) (44)
Individualized neuropathic pain therapy based on phenotyping: are we there yet? (2017) (43)
Docetaxel-induced Nail Changes – A Neurogenic Mechanism: A Case Report (2002) (43)
Different underlying pain mechanisms despite identical pain characteristics: A case report of a patient with spinal cord injury (2012) (42)
[Neuropathic pain. The long path from mechanisms to mechanism-based treatment]. (2000) (42)
Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open‐label, non‐comparative, flexible‐dose study (2008) (42)
Spontaneous oscillations of arterial blood pressure, cerebral and peripheral blood flow in healthy and comatose subjects. (1999) (42)
Idiopathic restless legs syndrome: (2004) (41)
Detection of a characteristic painful neuropathy in Fabry disease: a pilot study. (2008) (41)
262 A CROSS‐SECTIONAL SURVEY IN 2100 PATIENTS WITH PAINFUL DIABETIC NEUROPATHY AND POSTHERPETIC NEURALGIA: DIFFERENCES IN DEMOGRAPHIC DATA AND SENSORY SYMPTOMS (2010) (41)
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain (2013) (40)
Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials (2014) (38)
Sensory profiling in animal models of neuropathic pain: a call for back-translation (2017) (38)
Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy (2000) (38)
Quality assurance for Quantitative Sensory Testing laboratories: development and validation of an automated evaluation tool for the analysis of declared healthy samples (2015) (38)
How to detect a sensory abnormality (2008) (37)
Sensitization of the Nociceptive System in Complex Regional Pain Syndrome (2016) (37)
Individualized Pharmacological Treatment of Neuropathic Pain (2015) (36)
The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use (2016) (36)
Platelet Activation and Platelet-Leucocyte Interaction in Patients with Migraine. Subtype Differences and Influence of Triptans (2005) (36)
Enhancement of ectopic discharge in regenerating A- and C-fibers by inflammatory mediators. (2009) (35)
Phantom limb pain: are cutaneous nociceptors and spinothalamic neurons involved in the signaling and maintenance of spontaneous and touch-evoked pain? A case report (1995) (34)
Chronic pain: genes, plasticity, and phenotypes (2012) (34)
The relation between small nerve fibre function, age, disease severity and pain in Fabry disease. (2011) (33)
Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study (2015) (33)
No pain, still gain (of function): the relation between sensory profiles and the presence or absence of self-reported pain in a large multicenter cohort of patients with neuropathy. (2020) (33)
Misleading terms in Anderson‐Fabry disease (2008) (32)
Evaluation of symptom heterogeneity in neuropathic pain using assessments of sensory functions (2009) (32)
Activation of the somatosensory cortex during Aβ-fiber mediated hyperalgesia a MSI study (2000) (32)
Comparison of muscle and joint pressure-pain thresholds in patients with complex regional pain syndrome and upper limb pain of other origin (2014) (32)
Quantitative sensory testing in classical trigeminal neuralgia—a blinded study in patients with and without concomitant persistent pain (2016) (31)
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia (2012) (31)
High concentration capsaicin for treatment of peripheral neuropathic pain: effect on somatosensory symptoms and identification of treatment responders (2014) (30)
Tapentadol in the management of chronic low back pain: a novel approach to a complex condition? (2011) (30)
Clinical picture: nail changes secondary to docetaxel. (2001) (30)
Understanding chronic inflammatory and neuropathic pain (2012) (30)
Spinal and supraspinal processing of thermal stimuli: An fMRI study (2015) (29)
Optimal Treatment of Phantom Limb Pain in the Elderly (1998) (29)
Sympathetic and afferent neurons projecting in the splenic nerve of the cat (1988) (29)
Symptom profiles in the painDETECT Questionnaire in patients with peripheral neuropathic pain stratified according to sensory loss in quantitative sensory testing (2016) (29)
Mechano- and thermosensitivity of injured muscle afferents. (2011) (28)
[Procedure for certification of QST laboratories]. (2009) (28)
A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report (2007) (28)
Cutaneous afferent C‐fibers regenerating along the distal nerve stump after crush lesion show two types of cold sensitivity (2009) (28)
Assessment and diagnosis of neuropathic pain (2008) (28)
Spinal fMRI Reveals Decreased Descending Inhibition during Secondary Mechanical Hyperalgesia (2014) (28)
Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features (2011) (28)
Differential Expression and Functionality of TRPA1 Protein Genetic Variants in Conditions of Thermal Stimulation* (2012) (28)
Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge (2021) (27)
Post‐herpetic neuralgia case study: optimizing pain control (2004) (27)
Sensory bedside testing: a simple stratification approach for sensory phenotyping (2020) (26)
A case of neuropathic brachioradial pruritus caused by cervical disc herniation (2008) (26)
Prediction of response to tapentadol in chronic low back pain (2016) (26)
Axonal thermosensitivity and mechanosensitivity of cutaneous afferent neurons (2011) (24)
Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin (2021) (23)
A‐Fibers Mediate Cold Hyperalgesia in Patients with Oxaliplatin‐Induced Neuropathy (2018) (22)
The early influence of COVID-19 pandemic-associated restrictions on pain, mood, and everyday life of patients with painful polyneuropathy (2020) (22)
Complex Regional Pain Syndrome Type I: Neuropathic or Not? (2010) (22)
[Complex regional pain syndrome. Reflex sympathetic dystrophy and causalgia]. (2002) (22)
Painful Neuropathy: C‐Nociceptor Activity May Not Be Necessary to Maintain Central Mechanisms Accounting for Dynamic Mechanical Allodynia (1995) (22)
Reduced laser‐evoked potential habituation detects abnormal central pain processing in painful radiculopathy patients (2017) (22)
Axon-reflex reactions in affected and homologous contralateral skin after unilateral peripheral injury of thoracic segmental nerves in humans (1994) (21)
Interaction between histamine‐induced itch and experimental muscle pain (2004) (21)
A retrospective analysis of the long-term test–retest stability of pain descriptors of the painDETECT questionnaire (2016) (21)
Behavioral and sensory changes after direct ischemia‐reperfusion injury in rats (2007) (21)
Activation of the somatosensory cortex during Aβ-fiber mediated hyperalgesia - a MSI study (2000) (21)
Topical high‐concentration menthol: Reproducibility of a human surrogate pain model (2014) (20)
Is an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool based on IASP criteria (2014) (20)
Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge. (2010) (19)
Mechanisms of postherpetic neuralgia – We are hot on the scent (2008) (19)
Pain Drawings Improve Subgrouping of Low Back Pain Patients (2017) (19)
Neuropathic pain: Precise sensory profiling improves treatment and calls for back-translation (2014) (18)
DOLORisk: study protocol for a multi-centre observational study to understand the risk factors and determinants of neuropathic pain. (2018) (18)
Peripheral sensitization reduces laser-evoked potential habituation (2015) (18)
Improving the primary care physicians’ decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool (2014) (18)
Cold‐evoked potentials – Ready for clinical use? (2016) (17)
Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing. (2019) (17)
No effect of sympathetic sudomotor activity on capsaicin-evoked ongoing pain and hyperalgesia (2000) (17)
AAPT Diagnostic Criteria for Peripheral Neuropathic Pain: Focal and Segmental Disorders. (2019) (16)
Role of sympathetic nervous system in activity-induced cerebral perfusion (2010) (16)
Somatosensory processing in a German family with PINK1 mutations: its potential role in Parkinson disease (2009) (16)
Complex regional pain syndrome: an inflammatory pain condition? (2004) (16)
Stratification of neuropathic pain patients: the road to mechanism-based therapy? (2018) (15)
Postganglionic cholinergic dysautonomia with incomplete recovery: A clinical, neurophysiological and immunological case study (2004) (15)
Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment – the ComOn-study (2020) (15)
Responses of intact and injured sural nerve fibers to cooling and menthol. (2014) (15)
Somatosensory function in asymptomatic Parkin‐mutation carriers (2010) (15)
Prolonged maintenance of capsaicin-induced hyperalgesia by brief daily vibration stimuli (2007) (15)
Utility of transcutaneous electrical nerve stimulation in neurologic pain disorders (2010) (15)
Marchiafava-Bignami disease with recovery diagnosed by CT and MRI: demyelination affects several CNS structures (1989) (15)
The role of the sympathetic nervous system in autonomic disturbances and “sympathetically maintained pain” in CRPS (2001) (14)
Repetitive ipsilateral painful A‐delta fibre stimuli induce bilateral LEP amplitude habituation (2013) (14)
Neuropathic Pain: Translational research and impact for patient care (2006) (14)
Complex regional pain syndrome-a multifaceted disorder requiring multidimensional care: case study. (2007) (14)
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature (2020) (14)
Cutaneous noradrenaline measured by microdialysis in complex regional pain syndrome during whole-body cooling and heating (2013) (14)
No adrenergic sensitization of afferent neurons in painful sensory polyneuropathy (2006) (14)
Mechanistic and clinical aspects of complex regional pain syndrome (CRPS). (2004) (14)
painPREDICT: first interim data from the development of a new patient-reported pain questionnaire to predict treatment response using sensory symptom profiles (2019) (14)
Sensory symptoms in low back pain—how do they matter? (2018) (14)
Short Report: TRPV1-polymorphism 1911 A>G alters capsaicin-induced sensory changes in healthy subjects (2017) (13)
Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic pain (2019) (13)
Randomized controlled trial of the combined monoaminergic and opioid investigational compound GRT9906 in painful polyneuropathy (2012) (13)
Effect of sympathetic muscle vasoconstrictor activity on capsaicin‐induced muscle pain (2002) (13)
[Vasculitis course of neuroborreliosis with thalamic infarct]. (1997) (13)
The stiff limb syndrome – a new case and a literature review (2003) (13)
DOLORisk: study protocol for a multi-centre observational study to understand the risk factors and determinants of neuropathic pain (2018) (13)
Up-date on Clinical Management of Postherpetic Neuralgia and Mechanism-Based Treatment: New Options in Therapy (2018) (13)
Clinical Manifestation of Acute, Subacute, and Chronic Low Back Pain in Different Age Groups: Low Back Pain in 35,446 Patients (2018) (13)
FabryScan: a screening tool for early detection of Fabry disease (2012) (12)
[Complex regional pain syndrome. Sympathetic reflex dystrophy and causalgia]. (2003) (12)
Reflex sympathetic dystrophy and causalgia. (2004) (11)
Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients – subgroup analyses from three European clinical trials (2017) (11)
Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function (2021) (11)
5.57 – Neuropathic Pain: Clinical (2008) (11)
Do We Measure What Patients Feel?: An Analysis of Correspondence Between Somatosensory Modalities Upon Quantitative Sensory Testing and Self-reported Pain Experience (2017) (11)
Mechanisms of adrenosensitivity in capsaicin induced hyperalgesia (2007) (11)
Laser-evoked potentials in painful radiculopathy (2017) (10)
Pain thresholds and intensities of CRPS type I and neuropathic pain in respect to sex (2020) (10)
[Epidural spinal cord stimulation for therapy of chronic pain. Summary of the S3 guidelines]. (2011) (10)
Dynamic of the somatosensory system in postherpetic neuralgia (2018) (10)
Respiratory modulation of blood flow in normal and sympathectomized skin in humans. (1996) (10)
Central habituation and distraction alter C‐fibre‐mediated laser‐evoked potential amplitudes (2016) (10)
Neurogeriatrics—a vision for improved care and research for geriatric patients with predominating neurological disabilities (2020) (10)
Modulation of sensitized C‐fibers by adrenergic stimulation in human neuropathic pain (2008) (10)
Treatment of painful radiculopathies with capsaicin 8% cutaneous patch (2017) (10)
[Types of topical treatment for peripheral neuropathic pain : Mechanism of action and indications]. (2010) (9)
The serotonin receptor 2A (HTR2A) rs6313 variant is associated with higher ongoing pain and signs of central sensitization in neuropathic pain patients (2020) (9)
Dynamic cerebral autoregulation in stroke patients with a central sympathetic deficit (2011) (9)
Postherpetic neuralgia—fighting pain with fire (2008) (9)
Pain matters for central sensitization: sensory and psychological parameters in patients with fibromyalgia syndrome (2021) (9)
Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration (2021) (9)
[Pain therapy for Fabry's disease]. (2013) (9)
Pain: Clinical pain assessment: from bedside to better treatment (2009) (9)
Chapter 4 Reflex sympathetic dystrophy and causalgia (2004) (9)
Fabry disease – Pain doctors have to find the missing ones (2009) (9)
Acute neuropathic pain: equivalent or different to chronic neuropathic pain? A call for gathering of scientifically based information on acute neuropathic pain. (2019) (9)
Cold‐evoked potentials versus contact heat‐evoked potentials—Methodological considerations and clinical application (2019) (8)
Oxaliplatin-induced painful neuropathy – Flicker of hope or hopeless pain? (2009) (8)
SIGMA-1 Receptor Gene Variants Affect the Somatosensory Phenotype in Neuropathic Pain Patients. (2019) (8)
Protective role of natural killer cells in neuropathic pain conditions. (2021) (8)
Codon 101 of PRKCG, a preferential mutation site in SCA14 (2007) (8)
The need for previous knowledge does not render quantitative sensory testing a "failure" but part of a larger picture of the relationship between nociception and pain. (2021) (8)
A case of CLIPPERS syndrome responsive to tocilizumab (2019) (8)
A case of pain, motor impairment, and swelling of the arm after acute herpes zoster infection (2012) (8)
Bridging the Gap Between Vessels and Nerves in Fabry Disease (2020) (7)
Neurology—the next 10 years (2015) (7)
Contralateral Sensory and Pain Perception Changes in Patients With Unilateral Neuropathy (2021) (7)
[Recent trends in understanding and therapy of complex regional pain syndromes]. (2003) (7)
[Neuropathic pain. Basic principles for successful therapy]. (2002) (7)
Influence of intraoperative remifentanil and sufentanil on sensory perception: a randomized trial (2016) (7)
Localised neuropathic pain in the primary care setting: a cross-sectional study of prevalence, clinical characteristics, treatment patterns, quality of life and sleep performance (2020) (7)
Reflex inhibition of cutaneous and muscle vasoconstrictor neurons during stimulation of cutaneous and muscle nociceptors. (2014) (7)
Postherpetic neuralgia: Different pathophysiological mechanisms of pain (1998) (7)
Identification of sensory symptom clusters in patients with neuropathic pain based on the neuropathic pain symptom inventory questionnaire (2011) (7)
Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia. (2016) (7)
462 TOPICAL MENTHOL: STABILITY OF A SENSORY PROFILE IN A HUMAN SURROGATE MODEL (2007) (7)
Chapter 25 The autonomic nervous system and pain. (2006) (6)
Features and methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: a Delphi expert consensus study. (2022) (6)
Why are there no drugs indicated for sciatica, the most common chronic neuropathic syndrome of all? (2018) (6)
Fighting neuropathic pain with botulinum toxin A (2016) (6)
Sensory symptom profiles differ between trigeminal and thoracolumbar postherpetic neuralgia (2018) (6)
[Pathophysiology and treatment of complex regional pain syndromes]. (2003) (6)
chapter 26 – Complex Regional Pain Syndrome Type I (Reflex Sympathetic Dystrophy) (2007) (6)
Mechanism-based therapy for neuropathic pain-a concept in danger? (2015) (6)
Mechano- and thermosensitivity of injured muscle afferents 20 to 80 days after nerve injury. (2018) (6)
Small fibre function in primary autonomic failure (1993) (6)
Refractory Chronic Pain Screening Tool (RCPST): a feasibility study to assess practicality and validity of identifying potential neurostimulation candidates. (2014) (6)
Validation of the Questionnaire for Symptom Assessment in Pain disorders for Back pain patients (Q‐SAP) (2020) (5)
A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain? (2019) (5)
Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis. (2022) (5)
Do doctors treat themselves differently than their patients? Study on the self-treatment of migraine among German neurologists and pain specialists (2020) (5)
Evaluation of the antihyperalgesic effect of tapentadol in two human evoked pain models – the TapCapMentho pilot trial (2016) (5)
Sympathetically Maintained Pain (2003) (5)
Topical review Using screening tools to identify neuropathic pain (2007) (5)
Clinical features and pathophysiology of Complex Regional Pain Syndrome – current state of the art (2017) (5)
[Pharmacotherapy of chronic neuropathic pain]. (2019) (5)
Development of a bedside tool kit for assessing sensitization in patients with chronic osteoarthritis knee pain or chronic knee pain after total knee replacement. (2021) (4)
Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. (2022) (4)
An Update on Neuropathic Pain (2008) (4)
Spontaneous recurrent episodes of wrist pain in a 16-year-old girl: a case of complex regional pain syndrome (2016) (4)
Role of adrenergic transmitters and receptors in nerve and tissue injury related pain (2002) (4)
[Pain and pruritus : differences and similarities as revealed by the PainDetect questionnaire parameters]. (2012) (4)
Examination of the role of the cerebral cortex in the perception of pain using functional magnetic resonance imaging (1999) (4)
Postherpetic Neuralgia: Basic Research and Clinical Implications (2007) (4)
Oral or Topical Pain Therapy—How Would Patients Decide? A Discrete Choice Experiment in Patients with Peripheral Neuropathic Pain (2020) (4)
Neuroimaging Of Cold Allodynia Reveals A Central Disinhibition Mechanism Of Pain (2019) (4)
Pseudoradicular and radicular low-back pain – A disease continuum rather than different entities? Reply to the letters by Leffler and Hansson and by Van Boxem et al. (2008) (4)
Quality assurance for QST-laboratories: Development and validation of an automated evaluation tool for the analysis of declared healthy samples. (2015) (4)
Sodium channels in neuropathic pain—friend or foe? (2007) (4)
Differential coding of cold allodynia – A fmri study (2006) (3)
[Pain - a neglected neurological issue]. (2016) (3)
Making sense of sensory profiles. (2016) (3)
[Division-related function and organ-related therapy in Fabry's disease. An interdisciplinary challenge]. (2009) (3)
Association of sensory phenotype with quality of life, functionality, and emotional well-being in patients suffering from neuropathic pain (2021) (3)
Unusual Pain Disorders – What Can Be Learned from Them? (2021) (3)
[Comments on the paper by P. Hügler et al. The therapy of postherpetic zoster neuralgia]. (1994) (3)
228 QUANTITATIVE SENSORY TESTING IN PATIENTS SUFFERING FROM FIBROMYALGIA (2010) (3)
Therapy of Zoster Pain, Postherpetic Neuralgia and Other Neurological Complications (2006) (3)
Descending controls: Insurance against pain? (2011) (3)
Dynamic mechanical allodynia is not mediated by a central presynaptic interaction of aβ-mechanoceptive and nociceptive c-afferents (1998) (3)
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations (2021) (3)
Stratification of patients with unclassified pain in the FabryScan database (2019) (3)
Assessment of pain and somatosensory function in Fabry disease: early diagnosis. (2008) (3)
[Stepped analgesic approach to herpes zoster pain]. (2006) (2)
Neuropathic pain therapy: a puzzle of different approaches to stratify patients. (2020) (2)
Síndromes de dolor regional complejo (2006) (2)
Maximizing treatment efficacy through patient stratification in neuropathic pain trials (2022) (2)
safety/tolerability Of Tapentadol Prolonged Release (pr) Versus Oxycodone/ Naloxone Pr For Severe Chronic Low Back Pain With A Neuropathic Pain Component : wip-0229 (2014) (2)
One failed clinical trial (of 5HT3 antagonists) does not invalidate the concept (2012) (2)
A modality-specific somatosensory evoked potential test protocol for clinical evaluation: A feasibility study (2021) (2)
[Quantitative thermotest - investigations of thermal and nociceptive afferents in neuropathy. Is a multicentric approach useful to investigate rare painful neuropathies?]. (1998) (2)
Pathophysiological mechanisms of neuropathic pain (2000) (2)
510 ABNORMAL SOMATOSENSORY PROCESSING IN PINK1 (PARK6) MUTATION CARRIERS (2006) (2)
The impact of herpes zoster and subsequent chronic pain on patients’ daily lives (2010) (2)
[Pain prevention allows patients with chronic pruritus to itch from central sensitivity for itching]. (2005) (2)
[Endoscopic transthoracic sympathectomy in a paraneoplastic Raynaud's syndrome]. (1994) (2)
COMPLEX REGIONAL PAIN SYNDROME: EVOLVING UNDERSTANDING OF PATHOGENESIS AND IMPLICATIONS FOR TREAMENT (2009) (2)
Postherpetic Neuralgia and Other Neurologic Complications (2006) (2)
Should you stop wearing neckties?—wearing a tight necktie reduces cerebral blood flow (2018) (2)
178 PATTERNS OF ONGOING ACTIVITY IN CHRONICALLY INJURED MUSCLE AFFERENTS (2010) (2)
“From ear to trunk”—magnetic resonance imaging reveals referral of pain (2018) (2)
Size matters – Small fiber neuropathy in the Guillain–Barré syndrome (2010) (2)
[Neuropathic pain. How to open the blackbox]. (2015) (2)
39. Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type (2016) (2)
Definitions, Anatomical Localization, and Signs and Symptoms of Neuropathic Pain (2012) (2)
[Postherpetic neuralgia]. (2010) (2)
Capsaicin treatment in neuropathic pain: axon reflex vasodilatation after four weeks correlates with pain reduction. (2022) (2)
Peripheral burning cold pain (2006) (2)
Patient reported outcome measures in chronic neuropathic pain clinical trials - a systematic literature review. (2022) (2)
Test–retest reliability of a simple bedside-quantitative sensory testing battery for chronic neuropathic pain (2023) (2)
Cold allodynia: from the molecule to the clinic (2006) (2)
[Sympathetic nervous system and pain--some open questions]. (1998) (1)
Results from a randomized, controlled trial on efficacy and tolerability of a 5% Lidocaine-Medicated Plaster vs. Pregabalin in patients with Post-Herpetic Neuralgia (PHN) and Painful Diabetic Polyneuropathy (DPN) [poster] (2009) (1)
Corrigendum to “Value of quantitative sensory testing in neurological and pain disorders: NEUPSIG consensus” [PAIN® 2013;154(9):1807–1819] (2014) (1)
[Diagnosis of neuropathic pain]. (2007) (1)
Rapid reversal of haematoma expansion associated with vitamin K antagonists (2016) (1)
Kupfermangel als Differenzialdiagnose einer funikulären Myelose (2007) (1)
Response to letters by Oaklander et al. and Horowitz (2012) (1)
204 EXCITABILITY OF UNMYELINATED AFFERENT NERVE FIBERS BY PHYSIOLOGICAL STIMULI ALONG THE SURAL NERVE (2010) (1)
Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review (2022) (1)
„The natural history of post-traumatic reflex sympathetic dystrophy” (1998) (1)
CRPS: AN INFLAMMATORY PAIN CONDITION? A CASE OF FLUCTUATING PRESENCE OF CRPS. (2021) (1)
29 Topical Seminar Summary: NOVEL THERAPEUTIC OPTIONS FOR PERIPHERAL NEUROPATHIC PAIN (2009) (1)
Results from an interim analysis of a randomised, controlled trial on efficacy and tolerability of a 5 per cent lidocaine-medicated plaster vs pregabalin in patients with post-herpetic neuralgia (PHN) and painful diabetic polyneuropathy (DPN). (2009) (1)
Methodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release (2016) (1)
456 SOMATOSENSORY PROCESSING IN PINK1 (PARK6) AND PARKIN MUTATION CARRIERS: ITS POTENTIAL ROLE IN PARKINSON'S DISEASE (2007) (1)
S619 LOCALIZED NEUROPATHIC PAIN: A PROPOSED DEFINITION (2011) (1)
[The symptom sympathetic maintained pain]. (2003) (1)
Changes of Somatosensory Phenotype in the Course of Disease in Osteoarthritis Patients (2020) (1)
Bedside testing for precision pain medicine. (2021) (1)
The cornucopia of central disinhibition pain – An evaluation of past and novel concepts (2020) (1)
206 THERMO‐ AND MECHANOSENSITIVITY OF CUTANEOUS AFFERENT AXONS (2010) (1)
209 DISCHARGE CHARACTERISTICS OF REGENERATING MUSCLE AFFERENTS IN A CHRONICALLY LESIONED NERVE MODEL (2010) (1)
Reply to Vecht and Sillevis Smitt (1995) (1)
483 PATIENTS WITH POST-HERPETIC NEURALGIA (PHN) AND PAINFUL DIABETIC POLYNEUROPATHY (DPN) TREATED EITHER WITH 5% LIDOCAINE-MEDICATED PLASTER OR PREGABALIN (2010) (1)
chapter 27 – Complex Regional Pain Syndrome Type II (Causalgia) (2007) (1)
Contralateral sensitisation is not specific for complex regional pain syndrome. Comment on Br J Anaesth 2021; 127: e1-3. (2021) (1)
Neuropathic Pain: Mechanisms, Clinical Aspects and Treatment Options (2020) (1)
22 Topical Seminar Summary: NEUROPATHIC PAIN: DO WE NEED A NEW CLASSIFICATION? (2009) (1)
[Physicians do not treat averages--but therapy responders!]. (2012) (1)
The solitary nucleus connectivity to key autonomic regions in humans (2022) (1)
Bedside testing for precision pain medicine. (2021) (1)
[Treatment of polyneuropathy: autonomic symptoms and pain]. (2020) (1)
Complex regional pain syndromes: Taxonomy, diagnostic criteria, mechanisms of vascular abnormalites, edema, and pain (1997) (1)
[Prevention of postherpetic neuralgia: does it exist?]. (1997) (1)
Mechanisms underlying complex regional pain syndrome (2013) (1)
787 LONG‐TERM EFFICACY, SAFETY AND QUALITY OF LIFE WITH LIDOCAINE 5% MEDICATED PLASTER IN POST‐HERPETC NEURALGIA (2006) (1)
281 CHARACTERISTIC SENSORY PROFILE IN FABRY PATIENTS (2007) (1)
QUANTITATIVE ASSESSMENT AND CORRELATION OF SYMPATHETIC, PARASYMPATHETIC, AND EFFERENT SMALL FIBER FUNCTION IN PERIPHERAL NEUROPATHY (2000) (1)
Pseudoradicular and radicular low-back pain – A disease continuum rather than different entities? Rebuttal: Reply to the letter “Cheese and Chalk? Missing the real anatomy” by Breck McKay (2008) (1)
S242 CUTANEOUS NOREPINEPHRINE MEASURED IN COMPLEX REGIONAL PAIN SYNDROME DURING WHOLE‐BODY COOLING AND HEATING (2011) (1)
Impact of suggestion on the human experimental model of cold hyperalgesia after topical application of high‐concentration menthol [40%] (2018) (1)
Influence of Deep Brain Stimulation on the Autonomic Nervous System in Patients Suffering from Parkinson's Disease (2004) (0)
255 GENETIC POLYMORPHISMS IN TRP CHANNELS ARE ASSOCIATED WITH THE SOMATOSENSORY FUNCTION IN NEUROPATHIC PAIN PATIENTS (2010) (0)
Sensory symptoms in fibromyalgia patients suggest a nervous system involvement (2009) (0)
34 Workshop Summary: QUANTITATIVE SENSORY TESTING IN RESEARCH AND CLINICAL TRIALS (2007) (0)
Prolongation of mechanical hyperalgesia by non nociceptive afferent input (2005) (0)
PMS74 DEVELOPMENT OF A TOOL TO HELP IN THE EARLY DETECTION OF FIBROMYALGIA (FM) IN GENERAL PRACTICE IN EUROPE (2009) (0)
Cutaneous Sympathetic Vasoconstrictor Function in Multiple System Atrophy and Parkinson's Disease (2004) (0)
[Pregabalin--clinical evidence and experiences]. (2005) (0)
37 DEFINING RESPONDER PROFILES TO CURRENT AND EMERGING DRUG TREATMENT FOR NEUROPATHIC PAIN (2010) (0)
30 MECHANISM BASED THERAPEUTIC APPROACH OF PAINFUL NEUROPATHIES: WHERE ARE WE NOW? (2009) (0)
150 CAN WE MODEL COMPLEX REGIONAL PAIN SYNDROMES? (2006) (0)
S705 REFRACTORY CHRONIC PAIN SCREENING TOOL (RCPST): A FEASIBILITY STUDY TO ASSESS PRACTICALITY AND VALIDITY (2011) (0)
260 SCREENING FOR FABRY DISEASE (2010) (0)
7 COMPLEX REGIONAL PAIN SYNDROME (CRPS) (2009) (0)
The relevance of real-world data for the evaluation of neuropathic pain treatments. (2022) (0)
Are prostaglandines involved in the sympathetic-nociceptive interaction in humans? (2005) (0)
582 5% LIDOCAINE‐MEDICATED PLASTER: SPARING OF PREGABALIN DURING COMBINATION THERAPY OF POST‐HERPETIC NEURALGIA (PHN) AND PAINFUL DIABETIC POLYNEUROPATHY (DPN) (2009) (0)
Cheese and Chalk? Missing the real anatomy. Authors' reply (2008) (0)
[Pain and QST:.."measure what is measurable"...]. (2009) (0)
496 5% LIDOCAINE MEDICATED PLASTER IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS WITH IMPAIRED RENAL FUNCTION OR DEMONSTRATED INTOLERABILITY FOR PREGABALIN (2010) (0)
574 CAPSAICIN‐SENSITIVE VASOACTIVE C‐NOCICEPTORS — KEY FIBERS FOR UNDERSTANDING NEUROPATHIC PAIN? (2009) (0)
S168 SPINAL AND SUPRASPINAL PROCESSING OF CAPSAICIN-INDUCED HYPERALGESIA (2011) (0)
シンポジウム08―1 痛みの最新の病態と治療 Neuropathic pain-definition, mechanisms diagnosis and management (2011) (0)
Sympathetic pain again? (2002) (0)
The pandemic’s effect on a patient cohort with painful polyneuropathy in 2020: A longitudinal study on pain, mood, and everyday life (2022) (0)
33 IS THERE EVIDENCE FOR A MECHANISMS-ORIENTED APPROACH FOR THE EFFECTIVE PAIN MANAGEMENT? (2011) (0)
[Reducing pain by new forms of therapy]. (2004) (0)
TRP Gene Polymorphism and Disease Risk (2015) (0)
Pseudoradicular and radicular low-back pain – A disease continuum rather than different entities? Rebuttal: Reply to the letter by M. Schiltenwolf and M. Akbar (2008) (0)
Improving the Diagnosis of Fibromyalgia (FM) in Europe: Identification of Factors that Aid in the Detection of FM (2009) (0)
Characterization of the somatosensorysensory profile of male patients with Fabry disease (2007) (0)
Neurological Therapeutic goals in Fabry Disease: European Expert Consensus Recommendations (P1.316) (2018) (0)
Postherpetic neuralgia-mechanisms, prediction and prevention (2000) (0)
[Preventing a chronic course. Defending against onset]. (2007) (0)
23 HOW FAR CAN WE GET BY QUANTITATIVE SENSORY TESTING AND SKIN BIOPSIES? (2009) (0)
Ambroxol for neuropathic pain: hiding in plain sight? (2022) (0)
618: Is there a role for peripheral C nociceptors in pathopysiology and treatment of neuropathic pain after spinal cord injury – a case report (2007) (0)
149 Topical Seminar Summary: NEUROPATHIC PAIN IN PATIENTS AND ANIMAL MODELS: ARE WE LOOKING AT THE SAME THING? (2006) (0)
A glance into the Book of Abstracts — Second International Congress on Neuropathic Pain (2007) (0)
cooling and menthol Responses of intact and injured sural nerve fibers to (2014) (0)
550 5% LIDOCAINE‐MEDICATED PLASTER VS. PREGABALIN IN PATIENTS WITH POST‐HERPETIC NEURALGIA (PHN) AND PAINFUL DIABETIC POLYNEUROPATHY (DPN): A RANDOMIZED, CONTROLLED TRIAL (2009) (0)
Anti-convulsant Drugs: Differential Indications – Neuropathic Pain and Migraine (2020) (0)
[Rheumatic diseases and neuropathic pain : Diagnosis and treatment]. (2020) (0)
Cold pain converts into burning pain – thermosensitivity of menthol activated C nociceptors (2005) (0)
[Interview with Prof. Dr. Ralf Baron. Pain: toward causality oriented therapy]. (2014) (0)
Neuropathic pain : mechanisms and new treatment options (2008) (0)
Differential Expression of microRNAs in Serum of Patients with Chronic Painful Polyneuropathy and Healthy Age-Matched Controls (2023) (0)
Complex Regional Pain Syndrome: An Inflammatory Pain Condition? A Case of Fluctuating Presence of Complex Regional Pain Syndrome (2021) (0)
EFIC5-1139 Special Lecture and Plenary Session PERSONALIZED TREATMENT IN NEUROPATHIC PAIN: VISION BECOMES REALITY (2015) (0)
Neuropathic pain (NP) syndromes are chronic pain disorders that develop after a lesion of the peripheral or central nervous structures (2008) (0)
F251 DISTRIBUTION AND SYMMETRY OF NEUROPATHIC PAIN (2011) (0)
The hereditary anchored susceptibility to altered sensory nociception (2011) (0)
PAIN THERAPY IN CRITICAL CARE‐ADVANCED THERAPEUTIC CONCEPT BASED ON PATHOPHYSIOLOGY: 576 (2004) (0)
Role of sympathetic activity in subjects with experimental pain and patients with complex regional pain syndromes (CRPS) (1998) (0)
Sensory profiles in patients with low back pain with and without radiculopathy. (2022) (0)
Neuronsof TRPM8-Expressing Somatosensory Chemical and Cold Sensitivity of Two Distinct (2015) (0)
FabryScan —/INS; A screening tool for Fabry disease (2013) (0)
Is an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool (2013) (0)
IN76-FR-01 Update in neuropathic pain (2009) (0)
461 SPECIFIC SENSORY PROFILE IN FABRY PATIENTS WITH NEUROPATHIC PAIN (2006) (0)
T3. Emerging Drug Treatments for Neuropathic Pain (2010) (0)
[Neuropathic pain]. (2005) (0)
Neuropathic Pain - Diagnostic and Therapeutic Update (2008) (0)
9 SYMPATHETICALLY MAINTAINED PAIN IN HUMAN NEUROPATHIC PAIN (2009) (0)
Improving the Diagnosis of Fibromyalgia (FM) in Europe: Identification of Factors that Aid in the Detection of FM (2009) (0)
Peripheral burning cold pain. Author's reply (2006) (0)
779 HERPES ZOSTER AND POST‐HERPETIC NEURALGIA: ASPECTS OF DAILY LIFE AFFECTED BY PAIN (2009) (0)
Comprar Headache and Pain | Ralf Baron | 9780931092039 | Lippincott Williams & Wilkins (2013) (0)
T231 MICROCIRCULATION IN SKIN AND MUSCLE DURING VENOUS STASIS, ARTERIAL ISCHEMIA AND ORTHOSTATIC CHALLENGE IN PATIENTS WITH FIBROMYALGIA AND HEALTHY CONTROLS (2011) (0)
[Increased sensitivity to pain during long-term opiate treatment is not a general contraindication for opiate medication]. (2008) (0)
489 SOMATOSENSORY FINDINGS IN COMPLEX REGIONAL PAIN SYNDROME AND PERIPHERAL NERVE INJURY (2009) (0)
Treatment of Postherpetic Neuralgia: Subtypes and a Mechanism-Based Treatment (2017) (0)
F174 TOPICAL HIGH-CONCENTRATION MENTHOL - REPRODUCIBILITY OF A HUMAN SURROGATE MODEL OF NEUROPATHIC PAIN (2011) (0)
131 CHAIRMAN'S INTRODUCTION: TOPICAL LIDOCAINE — A NOVEL STANDARD TREATMENT FOR NEUROPATHIC PAIN (2007) (0)
62 TAPENTADOL IN SEVERE CHRONIC PAIN — EVIDENCE IN NEUROPATHIC AND LOW BACK PAIN (2010) (0)
Efficacy and safety of lidocaine 5% medicated plaster vs pregabalin; a randomised, controlled trial, in patients with painful diabetic polyneuropathy (DPN) (2010) (0)
Cytokine expression in serum and cerebro-spinal fluid in non-inflammatory polyneuropathies (2008) (0)
Corrigendum to “Different underlying pain mechanisms despite identical pain characteristics: A case report of a patient with spinal cord injury” [PAIN® 153 (7) (2012) 1537–1540] (2012) (0)
cme: Diagnosis and Treatment of Neuropathic Pain (2006) (0)
Somatosensory processing in asymptomatic PINK1- and PARKIN-mutation carriers (2007) (0)
472 ENDOTHELIAL DYSFUNCTION IN COLD TYPE CRPS (2006) (0)
Human brain activity during motor imagery and real finger movements (2002) (0)
Influence of deep brain stimulation and levodopa on signs and symptoms in Parkinson's disease (2009) (0)
Neurological treatment goes bacterial (2018) (0)
afferentsand thermosensitivity of injured muscle (2011) (0)
Headache and pain (2002) (0)
Pharmakotherapy of neuropathic pain - Individually tailored but embedded in an interdisciplinary and multimodal treatment concept (2007) (0)
Treatment of Neuropathic Pain: Old Concepts and Novel Advances (2004) (0)
515 A CROSS SECTIONAL COHORT SURVEY IN 1434 PATIENTS WITH FIBROMYALGIA: DEMOGRAPHIC DATA, CO‐MORBIDITIES AND SENSORY SYMPTOMS (2009) (0)
Modified somatosensory processing in PINK1 (PARK6)-mutation carriers: Preclinical evidence by the use of quantitative sensory testing (QST) (2006) (0)
583 COMBINATION THERAPY OF POST‐HERPETIC NEURALGIA (PHN) AND PAINFUL DIABETIC POLYNEUROPATHY (DPN) WITH 5% LIDOCAINE‐MEDICATED PLASTER AND PREGABALIN (2009) (0)
THU0478 IS NEUROPATHIC PAIN IN INFLAMMATORY RHEUMATIC DISORDERS AN UNDERESTIMATED PROBLEM? RESULTS FROM THE GERMAN PAINDETECT DATABASE (2020) (0)
Revealing the time course of laser‐evoked potential habituation by high temporal resolution analysis (2021) (0)
Sympathetic pain again? Authors' reply (2002) (0)
121 THE ROLE OF A-BETA FIBERS IN NEUROPATHIC PAIN (2010) (0)
In Reply. (2017) (0)
The descending pain modulation system predicts short term efficacy of multimodal pain therapy: an observational prospective cohort study (2021) (0)
35 QUANTITATIVE SENSORY TESTING IN RESEARCH (2007) (0)
Small-fiber-Neuropathien (2006) (0)
PHANTOM OR CENTRAL NEUROPATHIC PAIN ? AUTHORS' REPLY (1995) (0)
[Neuropathic pain-definition, mechanisms diagnosis and management]. (2011) (0)
Chapter 27 – Mechanisms and Treatment Strategy of Complex Regional Pain Syndromes (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ralf Baron?

Ralf Baron is affiliated with the following schools:

Kiel University

Ralf Baron's Academic­Influence.com Rankings

Why Is Ralf Baron Influential?

Ralf Baron's Published Works

Published Works

What Schools Are Affiliated With Ralf Baron?

Ralf Baron's AcademicInfluence.com Rankings